close
CBD

Case Study: CBD oil 'should be considered a treatment option' for autistic patients

Autism and CBD

Cannabidiol in the treatment of autism spectrum disorders: new case study

Administration of plant-derived CBD oil is safe and effective in treating autism-related symptoms and should be considered a viable treatment option for patients with this disorder, study finds of cases published in the journal Cureus.

A team of Canadian researchers evaluated the long-term use of a CBD oil containing 20mg of CBD and less than one mg of THC in a "non-verbal" child with a autism spectrum disorder. Prior to starting CBD treatment, the patient exhibited behavioral symptoms with outbursts of anger and physical aggression (punching, kicking, biting, headbutting, and scratching).

This case study aims to demonstrate the use of cannabidiol (CBD) with low dose tetrahydrocannabinol (THC) in the management of symptoms associated with Autism Spectrum Disorders (ASD) to improve the overall quality of life of these individuals. and their families. ASD is a neurodevelopmental disorder affecting cognitive development, behavior, social communication and motor skills.

Prior to starting CBD treatment, the patient exhibited behavioral symptoms with outbursts of anger and physical aggression (punching, kicking, biting, headbutting, and scratching). He required daily insulin injections, which were accompanied by acts of self-harm, including punches to the head and chest. The patient displayed inappropriate behaviors such as playing with feces and rocking on the floor to calm down (stimming). He was constantly frustrated by misunderstandings when interacting with others, as he was unable to verbally express his needs. He had difficulty falling asleep, taking one to four hours to fall asleep and sleeping a total of four to five hours a night with frequent awakenings. He needed diapers to pull every night due to his incontinence. The patient attended public school with support and struggled to do well in school. There were difficulties interacting with teachers and other students and following the rules.

to read :  Cannabis users need more anesthetics

After twice-daily treatment with CBD, the patient “experienced a reduction in negative behaviors, including violent outbursts, self-harming behaviors and sleep disturbances. There was an improvement in social interactions, concentration and emotional stability.”

The investigators concluded: “In the case study presented, the child patient showed behavioral and cognitive improvements with no reported side effects. … With the proliferation of clinical studies on the use of cannabidiol in the treatment of patients with mood disorders, anxiety, chronic pain and other behavioral problems, it should be considered as a treatment option in management of symptoms related to autism. »

The results are consistent with numerous other studies showing that the use of CBD-dominant cannabis or oral extracts is associated with improved symptoms in children with ASD. After initiating CBD, there was a significant reduction in overeating. His weight has not changed significantly, apart from the expected increase with maturation (current weight 52 kilograms). Self-injurious and violent behavior decreased with treatment, which made it easier to administer her daily insulin injections. The table below provides a comparison of patient behaviors and characteristics before and after starting CBD treatment.

to read :  Phytotherapy and cannabinoid acids
Before CBD treatmentAfter the CBD treatment
HbA1C: range of 9-10%*HbA1C: range 8-9%
Self-harming behaviorsMinimal self-harm behaviors
Inappropriate behaviorReduction of inappropriate behavior
Difficulty communicating verballyFollow simple instructions
Poor sleep time and quality (4-5 hours per night)Improved sleep time and quality (8-10 hours per night)
Poor school performanceImproved academic performance
2-4 hours in a sensory room at school30 minutes/day in a sensory room at school
Irregular diet (grazing)Regular meal intervals
A comparison of characteristics before and after the start of CBD treatment for the patient in the presented case
*(normal HbA1C < 5,7% and diabetic > 6,7% with treatment goal < 7%)
CBD: cannabidiol; HbA1c: hemoglobin A1c


Tags : autismCanadaTreatment
weedmaster

The author weedmaster

Media broadcaster and communications manager specializing in legal cannabis. Do you know what they say? knowledge is power. Understand the science behind cannabis medicine, while staying up to date with the latest health related research, treatments and products. Stay up to date with the latest news and ideas on legalization, laws, political movements. Discover tips, tricks and how-to guides from the most seasoned growers on the planet, including the latest research and findings from the scientific community on the medical qualities of cannabis.